All articles by Staff Writer
Staff Writer
Roche commits to diversity & inclusion in the Middle East with the signing of the Middle East Inclusion & Diversity Council Charter
Roche in the Middle East has reaffirmed its commitment to diversity and inclusion by signing the Middle East Inclusion & Diversity Council Charter. The company is among the latest companies that have pledged to accelerate greater gender balance in the region in line with the UN’s fifth sustainable development goal, which encourages an increase in the ratio of women in leadership positions to 30 percent by 2025.
Leading healthcare experts from MENA and beyond to explore the future of precision medicine in the region at PMES 23 this month
The future of medicine in the Middle East and North Africa is precise By 2030, the global market for precision medicine is expected to exceed $175bn PMES 23 is generously supported by the UAE’s MoIAT, MoHAP, DoH Abu Dhabi, and the DHA PMES 23 takes place 23-24 May 2023 at the Dubai World Trade Centre
Illumina’s genomic technologies enable better pathogen preparedness and response
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today recognized the progress and impact of genomic technologies on pathogen preparedness and response. Following the boost in sequencing infrastructure and capabilities driven by the COVID-19 pandemic, today genomic technologies are enabling public health agencies and health care systems to better prepare for, and respond to, pathogenic threats.
Topical Oxygen Therapy Awarded Positive Treatment Recommendation by the International Working Group on the Diabetic Foot in their 2023 Diabetic Foot Ulcer Guidelines
AOTI Inc, the global leader in multi-modality topical wound oxygen, announced exciting news from the 9th International Symposium on the Diabetic Foot (ISDF). The ISDF is often referred to as the Olympics of the Diabetic Foot, due to being held only every 4 years and the high quality of the clinical sessions.
Thermo Fisher Scientific Expands ImmunoCAP™ Test Availability Across U.S.
Testing supporting allergy diagnosis now accessible to more people in more communities
Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance With No Daily Maintenance
DxI 9000 Access Immunoassay Analyzer Boasts Industry’s Highest Throughput per Footprint: Up To 215 Tests/Hour/Square Meter Innovations Bolster Assay Performance and Laboratory Productivity with New Analyte Processing and Detection Technology, Precision Sensors, Smart Algorithms, Remote Real-Time System Monitoring, and is the Only Immunoassay Analyzer System with No Daily Maintenance i NT-proBNP Assay Now Available with Age-Based Cutoffs and Comorbidity Data
Randox Laboratories introduces Prostate-specific Antigen (PSA). This allows testing for indications of prostate cancer and other prostate conditions such as prostatitis and benign prostatic hyperplasia.
Produced by both normal and malignant prostate cells, PSA functions to liquify semen in the seminal coagulum allowing sperm cells to move freely and to dissolve the cervical mucus permitting the sperm cells migration to the uterus.
Randox Laboratories have introduced BNP1-32, an accepted clinical practice for the diagnosis of heart failure due to its high sensitivity and specificity.
Randox have released an automated test for levels of BNP, which is a protein made by your heart and blood vessels. Elevated levels of BNP are indicative of several comorbid conditions such as Congestive Heart Failure, Coronary Heart Disease, Atrial Fibrillation, Chronic Renal Failure and Chronic Respiratory Disease. It has additionally been shown to be associated with ischemic stroke and pre-eclampsia.
UPM Biomedicals enters the Switzerland Innovation Park Basel Area site Main Campus, Europe’s top life sciences hub
UPM Biomedicals is pleased to have established Basel, Switzerland, as the new bridgehead of introducing high quality nanofibrillar cellulose to life science and medical applications. UPM Biomedicals became a member of the Switzerland Innovation Park Basel Area resident community on 10 May and plans to open a cell lab in the premises later this year.
Two 3M Veraflo Therapy dressings receive first-ever FDA clearance for hydromechanical removal of non-viable tissue
Innovative therapy shown to help promote healing and reduce the need for surgical debridements creating potential savings for health care systems.